Generation and survival of midbrain dopaminergic neurons in weaver mice

International Journal of Developmental Neuroscience

Volumn 25, Issue 5, 2007, Pages 299-307

  Martí, Joaquín ^a   Santa Cruz, M C ^a   Bayer, Shirley A ^b   Ghetti, Bernardino ^c   Hervás, José P ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Laboratory of Developmental Neurobiology   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoradiography; Dopaminergic neurons; Immunocytochemistry; Midbrain; Neurogenesis; Weaver mice

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GENOTYPE; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; AUTORADIOGRAPHY; CELL PROLIFERATION; CELL SURVIVAL; DOPAMINE; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MICE; MICE, NEUROLOGIC MUTANTS; NEURONS; SUBSTANTIA NIGRA; THYMIDINE; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

MUS;

EID: 34447307650     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2007.05.002     Document Type: Article

References (63)

1. Agid Y., Ruberg M., Javoy-Agid F., Hirsch E., Raisman-Vozari R., Vyas S., Faucheux B., Michel P., Kastner A., Blanchard V., Damier P., Villares J., and Zhang P. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?. In: Narabayashi H., Nagatsu T., Yanagisawa N., and Mizuno Y. (Eds). Advances in Neurology vol. 60 (1993), Raven Press, New York 148-164
2. 28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice. Eur. J. Neurosci. 9 (1997) 120-127
3. Altman J., and Bayer S.A. Development of the brain stem in the rat. V. Thymidine-radiography study of the time of origin of neurons in the midbrain tegmentum. J. Comp. Neurol. 198 (1981) 677-716
4. Bayer S.A., and Altman J. Directions in neurogenetic gradients and patterns of anatomical connections in the telencephalon. Prog. Neurobiol. 29 (1987) 57-106
5. Bayer S.A., Wills K.V., Triarhou L.C., Thomas J.D., and Ghetti B. Systematic differences in time of dopaminergic neuron origin between normal mice and homozygous weaver mutants. Exp. Brain Res. 105 (1995) 200-208
6. Broome J.D., Wills K.V., Lapchak P.A., Ghetti B., Camp L.L., and Bayer S.A. Glial cell line-derived neurotrophic factor protects midbrain dopamine neurons from the lethal action of the weaver gene: a quantitative immunocytochemical study. Brain Res. Dev. Brain Res. 116 (1999) 1-7
7. Burke E.B. Parkinson's Disease. In: Koliatsos V.E., and Ratan R.R. (Eds). Cell Death and Diseases of the Nervous System (1999), Human Press Inc.
8. Burke R.E. Ontogenic cell death in the nigrostriated system. Cell Tissue Res. 318 (2004) 63-72
9. Chen S.H., Ehrhard P., Goldowitz D., and Smeyne R.J. Developmental expression of the GIRK family of inward rectifying potassium channels: implications for abnormalities in the weaver mutant mouse. J. Neurosci. 10 (1997) 720-733
10. Chinta S.J., and Anderson J.K. Dopaminergic neurons. Int. J. Biochem. Cell Biol. 37 (2005) 942-946
11. Choi-Lundberg D.L., and Bohn M.C. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Brain Res. Dev. Brain Res. 85 (1995) 80-88
12. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 (1999) 1437-1448
13. Eisenman L.M., Gallagher E., and Hawkes R. Regionalization defects in the weaver cerebellum. J. Comp. Neurol. 394 (1998) 431-444
14. 11C-Win 35, 428 reveals marked declines in mild Parkinson's disease. Ann. Neurol. 34 (1994) 323-431
15. 28 and of the dopaminergic mesocortical projections in weaver mutant mice. Neuroscience 61 (1994) 293-305
16. Gates M.A., Torres E.M., White A., Fricker-Gates R.A., and Dunnett S.B. Re-examining the ontogeny of substantia nigra dopamine neurons. Eur. J. Neurosci. 23 (2006) 1384-1390
17. German D.C., Dubach M., Askari S., Speciale S.G., and Bowden D.M. 1-methil-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?. Neuroscience 24 (1988) 161-174
18. German D.C., Manaye K., Smith W.K., Woodward D.J., and Saper C.B. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann. Neurol. 26 (1989) 507-514
19. Golden J.P., Baloh R.H., Kotzbauer P.T., Lampe P.A., Osborne P.A., Milbrandt J., and Johnson Jr. E.M. Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. J. Comp. Neurol. 398 (1998) 139-159
20. Graybiel A.M., Ohta K., and Roffler-Tarlov S. Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I. Gradients and compartments. J. Neurosci. 10 (1990) 720-733
21. Grondin R., Zhang Z., Yi A., Cass W.A., Maswood N., Andersen A.H., Elsberry D.D., Klein M.C., Gerhardt G.A., and Gash D.M. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 125 (2002) 2191-2201
22. Herrup K., and Trenkner E. Regional differences in cytoarchitecture of the weaver cerebellum suggest a new model for weaver gene action. Neuroscience 23 (1987) 871-885
23. Hirsch E., Graybiel A.M., and Agid Y. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334 (1988) 345-348
24. 28k-like immunoreactivity in catecholaminergic cell groups of the human midbrain: normal distribution and distribution in Parkinson's disease. Neurodegeneration 1 (1992) 83-93
25. 28k: a potencial neuroprotective protein. Neurodegeneration 3 (1994) 1-20
26. Kholodilov N., Yarygina O., Oo T.F., Zhang H., Sulzer D., Dauer W., and Burke R.E. Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. J. Neurosci. 24 (2004) 3136-3146
27. Kish S.J., Shannak K., and Hornnykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic parkinson's disease. N. Engl. J. Med. 318 (1988) 876-880
28. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., and Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290 (2000) 767-773
29. 28k exhibit reduced vulnerability to MTPT-induced neurodegeneration. Neurodegeneration 5 (1996) 313-318
30. Liss B., Neu A., and Roeper J. The weaver mouse gain-of-function phenotype of dopaminergic midbrain neurons is determined by coactivation of wwGirk2 and K-ATP channels. J. Neurosci. 15 (1999) 8839-8848
31. Liss B., Haeckel O., Wildmann J., Miki T., Seino S., and Roeper J. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat. Neurosci. 8 (2005) 1742-1751
32. Maricich S.M., Soha J., Trenkner E., and Herrup K. Failed cell migration and death of Purkinje cells and deep nuclear neurons in the weaver cerebellum. J. Neurosci. 17 (1997) 3675-3683
33. Martí J., Wills K.W., Ghetti B., and Bayer S.A. The weaver gene has no effect on the generation patterns of mesencephalic dopamine neurons. Brain Res. Dev. Brain Res. 122 (2000) 165-172
34. Martí J., Wills K.W., Ghetti B., and Bayer S.A. The weaver gene continues to target late-generated dopaminergic neurons in midbrain areas at P90. Brain Res. Dev. Brain Res. 122 (2000) 173-181
35. Martí J., Wills K.W., Ghetti B., and Bayer S.A. Evidence that the loss of Purkinje cells and deep cerebellar nuclei neurons in homozygous weaver is not related to neurogenetic patterns. Int. J. Dev. Neurosci. 19 (2001) 599-610
36. Martí J., Wills K.W., Ghetti B., and Bayer S.A. A combined immunohistochemical and autoradiographic method to detect midbrain neurons and determine their time of origin. Brain Res. Brain Res. Protoc. 9 (2002) 197-205
37. Matzuk M.M., and Saper C.B. Preservation of hypothalamic dopaminergic neurons in Parkinson's disease. Ann. Neurol. 18 (1985) 552-555
38. McCormack A.L., Atienza J.G., Langston J.W., and Di Monte D.A. Decrease susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to parqaquat-induced degeneration. Neuroscience 141 (2006) 929-937
39. 28k-containing neurons are restricted to the medial substatia nigra in humans. Neuroscience 65 (1995) 87-91
40. Oo T.F., Blazeski R., Harrison S.M., Henchcliffe C., Masson C.A., Roffler-Tarlov S., and Burke R. Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic. J. Neurosci. 16 (1996) 6134-6145
41. Oo T.F., Kholodilov N., and Burke R.E. Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal GDNF in vivo. J. Neurosci. 23 (2003) 5141-5148
42. Oo T.F., Ries V., Cho J., Kholodilov N., and Burke R.E. Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat. J. Comp. Neurol. 484 (2005) 57-67
43. Ozaki M., Hashikawa T., Ikeda K., Miyakawa Y., Ichikawa T., Ishihara Y., Kumanishi T., and Yano R. Degeneration of pontine mossy fibers during cerebellar development in weaver mutant mice. Eur. J. Neurosci. 16 (2002) 565-574
44. Patil N., Cox D.R., Bhat D., Faham M., Myers R.M., and Peterson A.S. A potassium channel mutation in weaver mice implicates membrane excitability in granule differentiation. Nat. Genet. 11 (1995) 126-129
45. Peng J., Xie L., Stevenson F.F., Melov S., Di Monte D.A., and Andersen J.K. Nigrostriatal dopaminergic neurodegeneration in the weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration. J. Neurosci. 26 (2006) 11644-11651
46. Puelles L., and Verney C. Early neuromeric distribution of tyrosine-immunoreactive neurons in human embryos. J. Comp. Neurol. 394 (1988) 283-308
47. Rakic P., and Sidman R.L. Sequence of development abnormalities leading to granule cell deficit in cerebellar cortex of weaver mutant mice. J. Comp. Neurol. 152 (1973) 103-132
48. Rodríguez M., Barroso-Chinea P., Abdala P., Obeso J., and González-Hernández T. doapmine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in Parkinson's disease. Exp. Neurol. 169 (2001) 163-181
49. Roffler-Tarlov S., and Graybiel A.M. The postnatal development of the dopamine-containing innervation of dorsal and ventral striatum: effects of the weaver gene. J. Neurosci. 7 (1987) 2364-2372
50. Roffler-Tarlov S., Pugatch D., and Graybiel A.M. Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver II. High affinity uptake sites for dopamine. J. Neurosci. 10 (1990) 734-740
51. Roffler-Tarlov S., Martin B., Graybiel A.M., and Kauer J.S. Cell death in the midbrain of the murine mutation weaver. J. Neurosci. 16 (1996) 1819-1826
52. Schein J.C., Hunter D.D., and Roffler-Tarlov S. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. Dev. Biol. 204 (1998) 432-450
53. Schmidt M.J., Sawyer B.D., Perry K.W., Fuller R.W., Foreman M.M., and Ghetti B. Dopamine deficiency in the weaver mutant mouse. J. Neurosci. 2 (1982) 376-380
54. Sekigucchi M., Nowakowski R.S., Nagato Y., Tanaka O., Guo H., Madoka M., and Abe H. Morphologial abnormalities in the hippocampus of the weaver mutant mouse. Brain Res. 696 (1995) 262-267
55. Sidman R.L., Angevine J.B., and Taber-Pierce E. Atlas of the Mouse Brain and Spinal cord (1971), Harvard University Press, Cambridge, MA
56. Smeyne R.J., and Goldowitz D. Developmental and death of external granular layer cells in the weaver mouse cerebellum: a quantitative study. J. Neurosci. 9 (1989) 1608-1620
57. Smits S.M., Burbach J.P.H., and Smidt M.P. Development origin and fate of meso-diencephalic dopamine neurons. Prog. Neurobiol. 78 (2006) 1-16
58. Tomac A., Lindqvist E., Kin L.-F.H., Agren S.O., Young D., Hoffer B.J., and Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF. Nature 373 (1995) 335-339
59. Triarhou L.C., Norton J., and Ghetti B. Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice. Exp. Brain Res. 70 (1988) 256-265
60. Uhl G.R., Hedreen J.C., and Price D.L. Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions. Neurology 35 (1985) 1215-1218
61. Verney C., Febvret-Muzerelle A., and Gaspar P. Early postnatal changes of the dopaminergic mesencephalic neurons in the weaver mutant mouse. Brain Res. Dev. Brain Res. 89 (1995) 115-119
62. 28K in the dopaminergic mesotelencephalic system in embryonic and fetal human brain. J. Comp. Neurol. 429 (2001) 45-58
63. 28k. Brain Res. 526 (1990) 303-307